Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 102-18: Microbiome, Gut, Hormones, Brain Connections in Mental Health/Addictions

    Contains 5 Component(s), Includes Credits

    Presenters: Wendy A. Henderson, PhD, MSN, CRNP, FAAN; Lorenzo Leggio, MD, PhD, MSc - 1.75 pharmacology contact hours

    102-18: Microbiome, Gut, Hormones, Brain Connections in Mental Health/Addictions

    This session includes the two presentations described below.

    This nurse researcher uses plain language to explain how she studies altered gut permeability in patients with previously negative clinical findings, revealing microscopic changes in the GI tract in response to stress. She is able to demonstrate with science that chronic abdominal pain is not just “all in your head”. 
    Presenter: Wendy A. Henderson, PhD, MSN, CRNP, FAAN

    This presentation details how gut-brain axis, using the neurohormone ghrelin, is studied in addictions research. Ghrelin signals the brain for food seeking and reward, and may help to explain alcohol seeking behaviors. The goal of this research is new drug development for the treatment of addictive disorders. 
    Presenter: Lorenzo Leggio, MD, PhD, MSc

    Disclosures: Lorenzo Leggio, MD, PhD, MSc has indicated a significant financial interest or other affiliation with UK MCA and Oxford Press (honorarium) and Routeledge (book royalties). Wendy A. Henderson, PhD, MSN, CRNP, FAAN, has no conflict of interest or commercial support to disclose. Off-label uses will be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

    Session Length:  1 Hour 52 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Explore the role of the microbiome-gut-brain axis in addictions and mental health.
    2. Discuss the complexity of the bidirectional communications between the brain and the periphery by providing examples from basic science and human research.

    Keywords: Gut-Brain Axis, Microbiome, Addictions, Research, Psychopharmacology


    Continuing Nursing Education:
    1.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Friday, June 8, 2018
    9:45am - 11:45am

    The contact hours for this session expire: December 31, 2020

  • 105-18: What’s Old Could Be New Again: Recognizing the Benefits and Neuroprotective Effects of Lithium

    Contains 5 Component(s), Includes Credits

    Presenter: Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC 1.25 pharmacology contact hours

    105-18:  What’s Old Could Be New Again: Recognizing the Benefits and Neuroprotective Effects of Lithium

    Using a case study approach, this presentation gives an overview of DSM 5 changes, indications and benefits of lithium for the treatment of Bipolar disorder. The learner will explore differences in phenotype related to efficacy of this old medication option. 


    Presenter:
      Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
      1 hour 20 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe cellular mechanisms of the actions of lithium.
    2. Explore potential mechanisms of effectiveness and loss of effect in the use of lithium.

    Keywords:  APRN Practice, Psychopharmacology


    Continuing Nursing Education:
    1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Friday, June 8, 2018
    4:00pm - 5:30pm


    The contact hours for this session expire: December 31, 2020

  • 2065-18: APNA Administrative Council Interactive Panel

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenters: Suzie Marriott, MS, BSN, RN-BC; Kristen Kichefski, MSN, MBA, RN-BC 1.0 contact hours

    2065-18: APNA Administrative Council Interactive Panel

    The purpose of this session is to address current issues facing psychiatric nurse administrators. Results of the administrative panel survey will be presented as well as resources and a summary of a literature search, to support the priority issues identified by survey respondents.


    Presenters:
      Suzie Marriott, MS, BSN, RN-BC; Kristen Kichefski, MSN, MBA, RN-BC

    Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
      54 minutes

    Target Audience:  RN, APRN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Identify the current issues facing psychiatric nurse administrators and strategies to address the needs of the changing PMH workforce.

    Keywords:  Nurse Administrators, RN Development, Leadership


    Continuing Nursing Education:
    1.0 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 32nd Annual Conference
    Columbus, Ohio
    Thursday, October 25, 2018
    5:00pm - 6:30pm

    The contact hours for this session expire:  December 31, 2020

  • 201-19: Managing Pharmacologic Treatment for Older Adults: Benzodiazepines and Antipsychotics

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Elizabeth Galik, PhD, CRNP, FAAN, FAANP 1.5 pharmacology contact hours

    201-19:  Managing Pharmacologic Treatment for Older Adults:  Benzodiazepines and Antipsychotics

    Focus on deprescribing benzodiazepines and antipsychotics when managing anxiety and agitation in older adults, explore alternative pharmacological options, and understand how to use these medications appropriately and safely when necessary.


    Presenter:
       Elizabeth Galik, PhD, CRNP, FAAN, FAANP

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose. Off-label use of medications will be discussed during this presentation.


    Session Length:
      1 hour 31 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Formulate treatment plans to address appropriate deprescribing practices of benzodiazepines and antipsychotics when used with older adults.
    2. Describe appropriate and safe prescribing practices of benzodiazepines and antipsychotics when used with older adults.

    Keywords:  Psychopharmacology, Older Adults, APRN Practice, Pharmacology


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented 
    APNA 17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Saturday, June 8, 2019
    8:00am - 9:30am


    The contact hours for this session expire:  June 30, 2021

  • 100-19: Deep Dive into Neurotransmitters: Focus on Glutamate and Gaba

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Debbie Thomas, Edd, APRN, PMHNP-BC, PMHCNS-BC, CMP 1.5 pharmacology contact hours

    100-19:  Deep Dive into Neurotransmitters: Focus on Glutamate and Gaba

    This course explores neurotransmitters, particularly glutamate and GABA, from a psychopharmacological perspective. This provides a better understanding of how this neurobiology relates to the lived experience of persons with mental health disorders.


    Presenter: 
    Debbie Thomas, Edd, APRN, PMHNP-BC, PMHCNS-BC, CMP

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Assurex Health, Inc. and Allergan, Inc. Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 25 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe the basic difference in the major neurotransmitters in mental health.
    2. Explain how GABA and glutamate play a role in mental health disorders from a humanistic patient perspective.

    Keywords:  Neurotransmitters, Psychopharmacology


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Thursday, June 6, 2019
    5:00pm - 7:00pm


    The contact hours for this session expire:  June 30, 2021

  • 101-19: New Evidence, New Delivery Methods, New Opportunities for Engaging Clients

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Rebecca S. Roma MD, MBA 1.5 pharmacology contact hours

    101-19:  New Evidence, New Delivery Methods,  New Opportunities for Engaging Clients

    Consider cutting edge scientific discoveries for treating schizophrenia. Update your background knowledge of the long-range costs, and the treatment options for this mental illness.


    Presenter:
      Rebecca S Roma MD, MBA

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Alkermes, Janssen Pharmaceuticals Inc., Neurocrine, Teva, and Otsuka America Pharmaceutical, Inc. Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 24 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe the course, continuity of care, and costs of schizophrenia.
    2. Explore oral medications and LAIs in a new paradigm for treatment of schizophrenia.

    Keywords:  Psychopharmacology, Long Acting Injectables, Schizophrenia

    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    8:00am - 9:30am


    The contact hours for this session expire:  June 30, 2021

  • 102-19: Complex Issues in Pediatric Psychopharmacology: Depressive & Anxiety Disorders

    Contains 5 Component(s), Includes Credits

    Presenter: Jeffrey R. Strawn, MD, FAACAP 1.5 pharmacology contact hours

    102-19:  Complex Issues in Pediatric Psychopharmacology: Depressive & Anxiety Disorders

    This course explores a wealth of data and strategy to inform prescribing practices for children and adolescents with depressive and anxiety disorders. Through antidepressant efficacy and tolerability data, gain insight into how to best meet the pharmacological needs of this pediatric population.


    Presenter:  Jeffrey R. Strawn, MD, FAACAP 

    Disclosures: The speaker has indicated a significant financial interest or affiliation with Myriad/Assurex , CMEology, Kansas University, Current Psychiatry, and  Springer Publishing. The speaker also receives research funding from NIH, Allergan, Neuronetics, Shire, Edgemont and the Yung Family Foundation. Off-label use of medications will be discussed during this presentation.The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 Hour 24 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe differences in efficacy and tolerability among antidepressant medications in pediatric patients with anxiety disorders.
    2. Describe individual differences in SSRI metabolism and exposure in pediatric patients and dosing implications.

    Keywords:  Psychopharmacology, Pediatrics


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    9:45am - 11:15am


    The contact hours for this session expire:  June 30, 2021

  • 104-19: Sexuality and Psychotropics

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Sattaria Dilks, DNP, APRN, PMHNP-BC 1.5 pharmacology contact hours

    104-19:  Sexuality and Psychotropics

    This presentation includes a candid discussion of the sexual side effects of psychotropic and non-psychotropic medications, that may interfere with consumer willingness to continue treatment. Hear eye opening cases to improve understanding and communication with the clients you serve.


    Presenter:   Sattaria Dilks, DNP, APRN, PMHNP-BC

    Disclosures:  The presenter has indicated a significant financial interest or other affiliation with Otsuka Speaker Bureau. Off-label use of medications will be discussed during this presentation.The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 22 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Discuss the impact of mental illness and commonly used psychiatric medications on sexuality. 
    2. Examine prescribing considerations related to psychiatric medications and adverse sexual issues and potential solutions to minimize pharmacologically based sexual issues.

    Keywords:  Psychopharmacology, Side Effects


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    1:45pm - 3:15pm


    The contact hours for this session expire:  June 30, 2021

  • 105-19: Ethical Considerations in Psychopharmacology

    Contains 5 Component(s), Includes Credits

    Presenters: Douglas P. Olsen, PhD, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN 1.5 pharmacology contact hours

    105-19:  Ethical Considerations in Psychopharmacology

    Discuss ethical considerations in psychopharmacological clinical practice with three nursing experts. Use an ethical decision-making framework to help navigate ethical dilemmas encountered by psychiatric-mental health nurses in clinical practice.


    Presenters:  Douglas P. Olsen, PhD, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN

    Disclosures: The speaker has indicated a significant financial interest or affiliation with Pfizer, and Johnson & Johnson. Off-label use of medications will not be discussed during this presentation.The activity planners have no conflict of interest to disclose.


    Session Length:
      1 hour 26 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Apply analytic techniques to different types of ethical dilemmas.
    2. Describe the basics of ethical prescribing including responsible practice, values identification, relational considerations with patients and industry, and issues of professional identity.

    Keywords:  Ethics, Decision Making

    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    3:30pm - 5:00pm


    The contact hours for this session expire:  June 30, 2021

  • 106-19: 2019 CPI Friday Outcomes Panel

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenters: Barbara J. Limandri, PhD, PMHCNS-BC; Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC; Brittany Yates, DNP, APRN, PMHNP-BC; Nick Guenzel, PhD, APRN-NP 0.5 pharmacology contact hours

    106-19:  2019 CPI Friday Outcomes Panel 

    In this panel, CPI Program Committee members will lead you through discussions about how the information in today’s sessions relate to your practice. They will also address questions submitted by attendees during the sessions. Through case study examples, information from the day will be highlighted and applied to psychopharmacologic nursing practice. These discussions will enable you to feel confident taking home new approaches for educating and providing care to your patients to ensure the best possible outcomes.


    Presenters:
      Barbara J. Limandri, PhD, PMHCNS-BC; Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC; Brittany Yates, DNP, APRN, PMHNP-BC; Nick Guenzel, PhD, APRN-NP

    Disclosures: Speaker Limandri has indicated an affiliation with the Journal of Psychosocial Nursing, and the American Psychiatric Nurses Association. The other panel speakers have no conflict of interest or commercial support to disclose. Off-label use of medications will not be discussed during this presentation.The activity planners have no conflict of interest to disclose.

     

    Session Length:  28 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Synthesize concepts and knowledge delivered in the presentations throughout the day.
    2. Discuss applications of the information presented to nursing psychopharmacologic practice. 

    Keywords:   APRN Practice, Case Study


    Continuing Nursing Education:
    0.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    5:00pm - 5:30pm


    The contact hours for this session expire:  June 30, 2021